News & Events

Dr. Shijie Cao aims to take advantage of the connection between our gut microbiome and immune responses to develop new treatments.

Dr. Ali Nili has helped treat many patients with pemphigus vulgaris, which causes painful blisters on the skin and inside the mouth, and he now hopes to develop a novel targeted treatment for the autoimmune disease at Dana-Farber Cancer Institute.

Dr. Ashlan J. Kunz Coyne of the University of Kentucky is studying how a bacteria called Stenotrophomonas maltophilia reacts to various antibiotic regimens.

Watch this PhRMA Foundation webinar to learn what it’s like to work at Lilly, a global medicine company, as a postdoctoral scientist.

Join this webinar to hear advice from researchers who have made the move from academia to industry.

In this webinar, PhRMA Foundation President Dr. Amy M. Miller discusses the importance of networking, with an emphasis on informational interviewing.

The PhRMA Foundation provided 2025 awards to 34 early-career scientists focused on drug discovery, drug delivery, and translational medicine research.

The PhRMA Foundation awarded $500,000 grants to two researchers to conduct studies using digital health technologies to improve health equity and health outcomes for patients.

The PhRMA Foundation provided 2024 awards to 11 early-career scientists conducting translational medicine and value assessment and health outcomes research.